Business
Eli Lilly’s approval of new Alzheimer’s drug will usher in a new era of treatment
With the advent of Lilly’s Kisunla, Alzheimer’s care could become more like cancer and rheumatoid arthritis treatment and conventional medications.
With the advent of Lilly’s Kisunla, Alzheimer’s care could become more like cancer and rheumatoid arthritis treatment and conventional medications.
